Pinnacle Bancorp’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Pinnacle Bancorp's GILD Position: Q1 2026 in Review
Pinnacle Bancorp increased its Gilead Sciences (GILD) stake by 16% in Q1 2026, buying an estimated $18.1K and bringing the position to 958 shares worth $134K. The position accounts for 0.04% of the portfolio, ranked #291.
Pinnacle Bancorp first reported a position in GILD in Q1 2017 and has held it in 31 quarters since. The position peaked at $149K in Q2 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Pinnacle Bancorp held 958 shares of Gilead Sciences worth $134K as of Q1 2026.
- Pinnacle Bancorp bought 129 Gilead Sciences shares in Q1 2026, an estimated $18.1K.
- Gilead Sciences made up 0.04% of Pinnacle Bancorp's portfolio in Q1 2026, its #291 holding.
- Pinnacle Bancorp first reported a position in Gilead Sciences in Q1 2017 and has held it in 31 quarters since.
- Pinnacle Bancorp's Gilead Sciences position peaked at $149K in Q2 2023.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Pinnacle Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.